XML 26 R19.htm IDEA: XBRL DOCUMENT

Capital Stock	9 Months Ended
Sep. 30, 2024
Equity [Abstract]
Capital Stock	11. CAPITAL STOCK As of September 30, 2024, the Company was authorized to issue 450,000,000 shares of common stock, $0.01 par value per share of which 11,267,253 were issued and outstanding. The Company was also authorized to issue 50,000,000 shares of preferred stock, $0.01 par value per share, of which none has been issued. On January 14, 2022, the Company entered into an At Market Offering Sales Agreement (the “Sales Agreement”) with B. Riley Securities, Inc. (the “Agent”) pursuant to which the Company may sell, from time to time, shares of common stock having an aggregate offering price of up to $15,000,000, through the Agent. There were no shares of common stock sold during the three and nine months ended September 30, 2024 and 2023, under the Sales Agreement.

Capital Stock

9 Months Ended

Sep. 30, 2024

11. CAPITAL STOCK

As of September 30, 2024, the Company was authorized to issue 450,000,000 shares of common stock, $0.01 par value per share of which 11,267,253 were issued and outstanding. The Company was also authorized to issue 50,000,000 shares of preferred stock, $0.01 par value per share, of which none has been issued.

On January 14, 2022, the Company entered into an At Market Offering Sales Agreement (the “Sales Agreement”) with B. Riley Securities, Inc. (the “Agent”) pursuant to which the Company may sell, from time to time, shares of common stock having an aggregate offering price of up to $15,000,000, through the Agent. There were no shares of common stock sold during the three and nine months ended September 30, 2024 and 2023, under the Sales Agreement.